|
Platelet function inhibitors
Citations 1-10 of 46 total displayed.
|
Most recent content
(1 Jun 2009):
|
- Original Contributions
Effect of Antiplatelet Therapy for Endovascular Coiling in Aneurysmal Subarachnoid Hemorrhage
- Walter M. van den Bergh, Richard S.C. Kerr, Ale Algra, Gabriel J.E. Rinkel, Andrew J. Molyneux for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group
Stroke 2009;40:1969-1972; published online before print as doi:10.1161/STROKEAHA.108.528802
[Abstract]
[Full text]
|
Past content
(since Jan 2002):
|
- Original Contributions
Abciximab Is a Safe Rescue Therapy in Thromboembolic Events Complicating Cerebral Aneurysm Coil Embolization: Single Center Experience in 42 Cases and Review of the Literature
- Thorsten Ries, Susanne Siemonsen, Ulrich Grzyska, Hermann Zeumer, and Jens Fiehler
Stroke 2009;40:1750-1757; published online before print as doi:10.1161/STROKEAHA.108.539197
[Abstract]
[Full text]
- Articles
Effect of Antiplatelet Therapy for Endovascular Coiling in Aneurysmal Subarachnoid Hemorrhage
- Walter M. van den Bergh, Richard S.C. Kerr, Ale Algra, Gabriel J.E. Rinkel, Andrew J. Molyneux for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group
Stroke published April 23, 2009, doi:10.1161/STROKEAHA.108.528802
[Abstract]
- Articles
Abciximab Is a Safe Rescue Therapy in Thromboembolic Events Complicating Cerebral Aneurysm Coil Embolization. Single Center Experience in 42 Cases and Review of the Literature
- Thorsten Ries, Susanne Siemonsen, Ulrich Grzyska, Hermann Zeumer, and Jens Fiehler
Stroke published March 19, 2009, doi:10.1161/STROKEAHA.108.539197
[Abstract]
- Cochrane Corner
Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage
- Sanne M. Dorhout Mees, Walter M. van den Bergh, Ale Algra, and Gabriel J.E. Rinkel
Stroke 2008;39:2186-2187; published online before print as doi:10.1161/STROKEAHA.107.509257
[Full text]
- Original Contributions
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke 2008;39:1482-1486; published online before print as doi:10.1161/STROKEAHA.107.500199
[Abstract]
[Full text]
- Cochrane Corner
Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease: An Update
- Els L.L.M. De Schryver, Ale Algra, and Jan van Gijn
Stroke 2008;39:1397-1398; published online before print as doi:10.1161/STROKEAHA.107.499723
[Full text]
- Cochrane Corner
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke 2008;39:1399-1400; published online before print as doi:10.1161/STROKEAHA.107.500363
[Full text]
- Articles
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500363
[Abstract]
- Articles
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500199
[Abstract]
|
|
